Mutations in gyrB play an important role in ciprofloxacin-resistant Pseudomonas aeruginosa

References

• WeinerLMWebbAKLimbagoBAntimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014Infect Control Hosp Epidemiol201637111288130127573805
   PubMed Web of Science ®Google Scholar
• BassettiMVenaACroxattoARighiEGueryBHow to manage infectionsDrugs Context2018721252729872449
   PubMedGoogle Scholar
• NguyenLGarciaJGruenbergKMacdougallCMultidrug-resistant Pseudomonas infections: hard to treat, but hope on the horizon?Curr Infect Dis Rep20182082329876674
   PubMed Web of Science ®Google Scholar
• ShariatiAAzimiTArdebiliAInsertional inactivation of oprD in carbapenem-resistant Pseudomonas aeruginosa strains isolated from burn patients in Tehran, IranNew Microbes New Infect201821758029234497
   PubMedGoogle Scholar
• QiZDuanMLiAResearch status of drug resistance mechanism of Pseudomonas aeruginosaShandong Med J20145448386
   Google Scholar
• MoradaliMFGhodsSRehmBHPseudomonas aeruginosa lifestyle: a paradigm for adaptation, survival, and persistenceFront Cell Infect Microbiol201773928261568
   PubMed Web of Science ®Google Scholar
• NguyenKNguyenTNguyenHLeDMutations in the gyrA, parC, and mexR genes provide functional insights into the fluoroquinolone-resistant isolated in VietnamInfect Drug Resist20181127528229535543
   PubMed Web of Science ®Google Scholar
• JedreyHLilleyKSWelchMCiprofloxacin binding to GyrA causes global changes in the proteome of Pseudomonas aeruginosaFEMS Microbiol Lett201836513
   Web of Science ®Google Scholar
• NouriRAhangarzadeh RezaeeMHasaniAAghazadehMAsgharzadehMThe role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from IranBraz J Microbiol201647492593027522930
   PubMed Web of Science ®Google Scholar
• GorganiNAhlbrandSPattersonAPourmandNDetection of point mutations associated with antibiotic resistance in Pseudomonas aeruginosaInt J Antimicrob Agents200934541441819656662
   PubMed Web of Science ®Google Scholar
• DrlicaKMalikMKernsRJZhaoXQuinolone-mediated bacterial deathAntimicrob Agents Chemother200852238539217724149
   PubMed Web of Science ®Google Scholar
• HuFGuoYZhuDSurveillance of CHINET bacterial resistance in ChinaChin J Infect Chemother2017175481491
   Google Scholar
• Ben NejmaMSioudOMastouriMQuinolone-resistant clinical strains of Pseudomonas aeruginosa isolated from University Hospital in Tunisia3 Biotech2018811
   Google Scholar
• VingopoulouEIDelisGABatziasGCPrevalence and mechanisms of resistance to fluoroquinolones in Pseudomonas aeruginosa and Escherichia coli isolates recovered from dogs suffering from otitis in GreeceVet Microbiol201821310210729291992
   PubMed Web of Science ®Google Scholar
• YangXXingBLiangCYeZZhangYPrevalence and fluoroquinolone resistance of Pseudomonas aeruginosa in a hospital of South ChinaInt J Clin Exp Med2015811386139025785142
   PubMed Web of Science ®Google Scholar
• SalmaRDabboussiFKassaaIKhudaryRHamzeMgyrA and parC mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa from Nini Hospital in north LebanonJ Infect Chemother2013191778122821356
   PubMed Web of Science ®Google Scholar
• MatsumotoMShigemuraKShirakawaTMutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 114 clinical isolates of Pseudomonas aeruginosa derived from urinary tract infections and their rapid detection by denaturing high-performance liquid chromatographyInt J Antimicrob Agents201240544044422884856
   PubMed Web of Science ®Google Scholar
• FengYJonkerMJMoustakasIBrulSTer KuileBHDynamics of mutations during development of resistance by Pseudomonas aeruginosa against five antibioticsAntimicrob Agents Chemother20166074229423627139485
   PubMed Web of Science ®Google Scholar
• AraisLRBarbosaAVCarvalhoCACerqueiraAMAntimicrobial resistance, integron carriage, and gyrA and gyrB mutations in Pseudomonas aeruginosa isolated from dogs with otitis externa and pyoderma in BrazilVet Dermatol2016272113e3126833540
   PubMed Web of Science ®Google Scholar
• de La FuenteCMDaurosSPBelloTHMutations in gyrA and gyrB genes among strains of Gram-negative bacilli isolated from Chilean hospitals and their relation with resistance to fluoroquinolonesRev Med Chil200713591103111018064363
   PubMed Web of Science ®Google Scholar
• CockerillFRPerformance Standards for Antimicrobial Susceptibility Testing: Twenty-First Informational SupplementWayne, PAClinical and Laboratory Standards Institute2017
   Google Scholar
• GaoYDuanJGengXDeficiency of quorum sensing system inhibits the resistance selection of Pseudomonas aeruginosa to ciprofloxacin and levofloxacin in vitroJ Glob Antimicrob Resist20171011311928729210
   PubMed Web of Science ®Google Scholar
• BruchmannSDötschANouriBChabernyIFHäusslerSQuantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistanceAntimicrob Agents Chemother20135731361136823274661
   PubMed Web of Science ®Google Scholar
• LiJXieSAhmedSAntimicrobial activity and resistance: influencing factorsFront Pharmacol2017836428659799
   PubMed Web of Science ®Google Scholar
• AllenGPHarrisKAIn vitro resistance selection in Shigella flexneri by azithromycin, ceftriaxone, ciprofloxacin, levofloxacin, and moxifloxacinAntimicrob Agents Chemother2017617
   Web of Science ®Google Scholar
• DayTHuijbenSReadAFIs selection relevant in the evolutionary emergence of drug resistance?Trends Microbiol201523312613325680587
   PubMed Web of Science ®Google Scholar
• CantónRMorosiniMIEmergence and spread of antibiotic resistance following exposure to antibioticsFEMS Microbiol Rev201135597799121722146
   PubMed Web of Science ®Google Scholar
• HansenGTZhaoXDrlicaKBlondeauJMMutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosaInt J Antimicrob Agents200627212012416426820
   PubMed Web of Science ®Google Scholar
• Shun-MeiEZengJMYuanHLuYCaiRXChenCSub-inhibitory concentrations of fluoroquinolones increase conjugation frequencyMicrob Pathog2018114576229174700
   PubMed Web of Science ®Google Scholar
• RenLHuangZLiwangYCDrug resistance and cross resistance of mutidrug resistant Mycobacterium tuberculosis to fluoroquinolones in vitroChina Pharm20151114881490
   Google Scholar
• XuchengShenXLiuMLiJDaiYIn vitro induction of resistance and cross resistance to five quinolones in Salmonella pullorumChina Poult20173992023
   Google Scholar
• LópezCATraversTPosKMZgurskayaHIGnanakaranSDynamics of intact MexAB–OprM efflux pump: focusing on the MexA–OprM interfaceSci Rep2017711652129184094
   PubMed Web of Science ®Google Scholar
• HelmyOMKashefMTDifferent phenotypic and molecular mechanisms associated with multidrug resistance in Gram-negative clinical isolates from EgyptInfect Drug Resist20171047949829263684
   PubMed Web of Science ®Google Scholar
• AdabiMTalebi-TaherMArbabiLSpread of efflux pump overexpressing-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa by using an efflux pump inhibitorInfect Chemother20154729810426157587
   PubMedGoogle Scholar
• YangWZhangMZhouJPangLWangGHouFThe molecular mechanisms of ciprofloxacin resistance in clinical Campylobacter jejuni and their genotyping characteristics in Beijing, ChinaFoodborne Pathog Dis201714738639228696791
   PubMed Web of Science ®Google Scholar
• MuruganNMalathiJThereseKLMadhavanHNApplication of six multiplex PCR’s among 200 clinical isolates of Pseudomonas aeruginosa for the detection of 20 drug resistance encoding genesKaohsiung J Med Sci2018342798829413231
   PubMed Web of Science ®Google Scholar
• HuMWangBFuLInduction and stability of Mycobacterium tuberculosis resistance to PA-824 in vitroChin J Antibiot2017422108112
   Google Scholar